Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Haan

Showing results (211-220 of 223) with videos related to

Pageof 23
Sort By:
Cephalalgia : an International Journal of Headache|November 25, 2005
The 3p21.1-p21.3 hereditary vascular retinopathy locus increases the risk for Raynaud's phenomenon and migraineJ J Hottenga, K R J Vanmolkot, E E Kors, et al.
Neuropediatrics|January 20, 2007
Alternating hemiplegia of childhood: no mutations in the glutamate transporter EAAT1B de Vries, J Haan, A H Stam, et al.
Annals of the Rheumatic Diseases|October 31, 2009
TREX1 gene variant in neuropsychiatric systemic lupus erythematosusB de Vries, G M Steup-Beekman, J Haan, et al.
Cephalalgia : an International Journal of Headache|May 24, 2008
CACNA1A mutation linking hemiplegic migraine and alternating hemiplegia of childhoodB de Vries, A H Stam, F Beker, et al.
Journal of Neurology|November 7, 2002
Episodic ataxia type 2. Three novel truncating mutations and one novel missense mutation in the CACNA1A geneA M J M van den Maagdenberg, E E Kors, E R Brunt, et al.
Journal of Internal Medicine|November 10, 2018
Systemic features of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: a monogenic small vessel diseaseN Pelzer, E S Hoogeveen, J Haan, et al.
Clinical Genetics|April 11, 2008
CACNA1A R1347Q: a frequent recurrent mutation in hemiplegic migraineA H Stam, K R J Vanmolkot, H P H Kremer, et al.
Cell|November 1, 1996
Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4R A Ophoff, G M Terwindt, M N Vergouwe, et al.
Journal of Thrombosis and Thrombolysis|February 22, 2025
Apixaban versus warfarin for treatment of venous thromboembolism in patients with severe renal impairment: a multicenter studyPaige Hanke, Ma Emmanuelle Domingo, Ghenella Salanio, et al.
Annals of Neurology|January 27, 2006
Severe episodic neurological deficits and permanent mental retardation in a child with a novel FHM2 ATP1A2 mutationK R J Vanmolkot, H Stroink, J B Koenderink, et al.
Pageof 23

Showing results (211-220 of 223) with videos related to

Sort By:
Pageof 23
Cephalalgia : an International Journal of Headache|November 25, 2005
The 3p21.1-p21.3 hereditary vascular retinopathy locus increases the risk for Raynaud's phenomenon and migraineJ J Hottenga, K R J Vanmolkot, E E Kors, et al.
Neuropediatrics|January 20, 2007
Alternating hemiplegia of childhood: no mutations in the glutamate transporter EAAT1B de Vries, J Haan, A H Stam, et al.
Annals of the Rheumatic Diseases|October 31, 2009
TREX1 gene variant in neuropsychiatric systemic lupus erythematosusB de Vries, G M Steup-Beekman, J Haan, et al.
Cephalalgia : an International Journal of Headache|May 24, 2008
CACNA1A mutation linking hemiplegic migraine and alternating hemiplegia of childhoodB de Vries, A H Stam, F Beker, et al.
Journal of Neurology|November 7, 2002
Episodic ataxia type 2. Three novel truncating mutations and one novel missense mutation in the CACNA1A geneA M J M van den Maagdenberg, E E Kors, E R Brunt, et al.
Journal of Internal Medicine|November 10, 2018
Systemic features of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: a monogenic small vessel diseaseN Pelzer, E S Hoogeveen, J Haan, et al.
Clinical Genetics|April 11, 2008
CACNA1A R1347Q: a frequent recurrent mutation in hemiplegic migraineA H Stam, K R J Vanmolkot, H P H Kremer, et al.
Cell|November 1, 1996
Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4R A Ophoff, G M Terwindt, M N Vergouwe, et al.
Journal of Thrombosis and Thrombolysis|February 22, 2025
Apixaban versus warfarin for treatment of venous thromboembolism in patients with severe renal impairment: a multicenter studyPaige Hanke, Ma Emmanuelle Domingo, Ghenella Salanio, et al.
Annals of Neurology|January 27, 2006
Severe episodic neurological deficits and permanent mental retardation in a child with a novel FHM2 ATP1A2 mutationK R J Vanmolkot, H Stroink, J B Koenderink, et al.
Pageof 23